Lightning Round: The infrastructure play is still on, says Jim Cramer
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Jim Cramer While Discussing Johnson & Johnson: 'It's Still Too Early to Buy the Momentum Stocks'
Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer recently commented on. Cramer discussed the stock in light of its latest quarter and analyst sentiment around it. He said: 'Sometimes you get these days where it feels like the market has returned to some semblance of what you're used to when things get shaky. I mean, these are the days when J&J will reign supreme… My guess is that there'll be maybe two or even maybe three days where interest rates are lower. This was day one, and you have to wait as the food and drug analysts come out from under the table and start bragging loudly about their flock and about how it's time to buy. That's what those guys always do… Which analysts are going to resist going out positive on J&J, which has moved up every day seemingly since the last quarter, maybe since they announced that quarter. Maybe the food analysts can talk up mergers… They're reasonable presumptions, and they'll preclude a serious tech rally or a speculative surge. Hear what I said, preclude. It's still too early to buy the momentum stocks.' Trong Nguyen / Johnson & Johnson (NYSE:JNJ) develops and sells a wide range of healthcare products, including prescription treatments for major diseases and advanced medical technologies. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 hours ago
- Yahoo
Jim Cramer on Goldman Sachs: 'I'm a Believer'
The Goldman Sachs Group, Inc. (NYSE:GS) is one of the stocks that Jim Cramer looked at. A caller asked if the company's private credit unit will continue doing highly leveraged deals like the one in the Walgreens-Shields transaction. Cramer replied: 'I don't know. You know Sweeney, Rob Sweeney, my friend Rob Sweeney, or my wife would say an acquaintance, Rob Sweeney, is doing that deal, and he's real money, good. So I see why they might have done that. And Tim Wentworth's there too. I don't know. I mean, I'm a believer. I wouldn't leave that deal even if I tried.' Photo by Akshay Sadarangani on Unsplash Goldman Sachs (NYSE:GS) delivers financial services including investment advisory, underwriting, lending, asset and wealth management, private banking, and digital financial solutions. On July 16, Cramer discussed the company's latest quarterly report. He commented: 'The single best report of the big banks came from Goldman Sachs, another Charitable Trust holding… really bailed me out on this one… They changed the… CEO of this today… Goldman blew away the numbers. I think they may have had the best quarter ever… While we acknowledge the potential of GS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
13 hours ago
- Business Insider
IONQ CEO Says ‘The Era of Quantum Supremacy Is Just Around the Corner'
IonQ (IONQ) CEO Niccolo de Masi stated during a CNBC interview with Jim Cramer that the era of quantum supremacy, meaning when quantum computers will solve problems impossible for classical computers, is just around the corner. He expects major advances in quantum computing within a few 'quarters or within low single-digit years.' This, he says, is generating excitement about how quantum computing will impact every area of applied science. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. A Quick Look at Quantum Computing IonQ is one of the leading players in the quantum computing space, competing for dominance with others, including Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and Quantum Computing (QUBT). Notably, IonQ is on track to develop both quantum computers and quantum networking equipment. Quantum networking refers to highly secured communication networks that are critical in fields such as banking, government, and telecommunications. Moreover, the CEO noted that IonQ is racing ahead of China in cracking current encryption methods like RSA, giving it a competitive edge and aligning with national security interests. Over the past year, IONQ stock has surged over 453% on the hope of this breakthrough. Why Is Quantum Computing the Next Big Thing? De Masi believes that quantum computing will soon provide a narrow commercial advantage, then progress to broader advantages, and ultimately achieve quantum supremacy. He highlighted that IonQ's systems operate at room temperature with high accuracy, scale rapidly, and have strong revenue growth. Quantum technology holds promise for breakthroughs in applications like healthcare and pharmaceuticals, including drug discovery. IonQ has a partnership with Nvidia (NVDA), Amazon Web Services (AMZN), and AstraZeneca (AZN), which aims to explore molecules through a quantum lens. To conclude, IonQ's CEO forecasts that quantum supremacy is imminent and will revolutionize applied science sectors by solving problems beyond classical computing's reach, with real-world applications emerging soon. There is growing interest in quantum computing from Wall Street and tech giants such as Alphabet (GOOGL), Microsoft (MSFT), Amazon, and IBM (IBM), as well as from the U.S. government, underscoring the commercial and scientific potential of this technology. Is IONQ Stock a Buy, Hold, or Sell? average IONQ price target of $43 implies 2.1% downside potential from current levels.
